2ME-28917-23710
2 vaccinations
5 coded responses
21 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 606 / IL
- Registered
- 2022-07-10
- Relationship
- Child or adolescent in my care
- Guardian
- 5SP-32477-66732
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-07-10
Registered in v-safe
-
2022-07-10
Dose 1 — Moderna
- 2022-07-10
- 2022-07-12
- 2022-07-13
- 2022-07-14
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-24
- 2022-07-31
-
2022-08-07
Dose 2 — Moderna
- 2022-08-07
- 2022-08-09
- 2022-08-10
- 2022-08-13
- 2022-08-14
- 2022-08-21
-
2022-08-28
Survey response — day 21, dose 2, under 3MedDRA: Cough, Diarrhoea, Respiratory tract congestion — Feeling: PoorFree text: Congestion, coughing, diarrhea.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-04
Survey response — day 28, dose 2, under 3MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose, congestion, cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-11
Survey response — day 35, dose 2, under 3MedDRA: Eye discharge, Increased upper airway secretion, Rhinorrhoea, Secretion discharge — Feeling: FairFree text: Eye discharge, increases mucus in throat, runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-18
-
2022-11-06
Survey response — 3 months, dose 2, under 3MedDRA: Diarrhoea, Vomiting — Feeling: FairFree text: Vomiting and diarrheaMedDRA releases: 2024-11 · check-in free text available
-
2023-02-05
Survey response — 6 months, dose 2, under 3MedDRA: Productive cough, Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-10 | Moderna | No |
| 2 | 2022-08-07 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Congestion, coughing, diarrhea.
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Runny nose, congestion, cough.
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Eye discharge, increases mucus in throat, runny nose.
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Vomiting and diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Eye discharge | · | · | ✓ |
| SD | Increased upper airway secretion | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release